Bipolar Disorder Trial, Recruiting NCT06462196 Sponsor: National Institute of Mental Health (NIMH) Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06462196
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have already signed consent for a related NIH study called Protocol 01-M-0254 (The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers)
  • People who are able to give informed consent to participate
  • People who can read and write in English

Who may not be able to join:

  • People with unstable medical conditions that the study doctor believes would make it unsafe to take part in outpatient or inpatient treatment
  • People who are pregnant
  • People who are participating in Protocol 01-M-0254 as a healthy volunteer (rather than as a patient)
  • People who have had a significant problem with drugs or alcohol (other than caffeine or nicotine) in the three months before the study, or who have a moderate to severe alcohol use disorder in that same period
  • People who have used illicit drugs or drugs known to be misused (other than caffeine or nicotine) in the two weeks before giving consent, or who test positive on a urine drug test before enrolling (prescribed benzodiazepines or stimulants may be acceptable — confirm with trial site)
  • People who use cannabis daily, are unable to stop using cannabis during the study, or whose daily functioning is affected by cannabis use, as assessed by a clinician

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elizabeth D Ballard, Ph.D., National Institute of Mental Health (NIMH)

Phone: (877) 646-3644

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 September 2024
Est. completion
1 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Score on Montgomery Asberg Depression Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov